Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Down - Time to Sell?

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient shares opened at $70.65 after a gap down from a previous close of $73.36, with a trading volume of 120 shares.
  • Analysts have given Eurofins Scient a consensus rating of "Hold," with Citigroup restating a "neutral" rating and one analyst rating it as a Strong Buy.
  • The company maintains a quick ratio of 1.19 and a debt-to-equity ratio of 0.77, indicating stable financial health amidst recent stock fluctuations.
  • MarketBeat previews top five stocks to own in October.

Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) shares gapped down before the market opened on Wednesday . The stock had previously closed at $73.36, but opened at $70.65. Eurofins Scient shares last traded at $70.65, with a volume of 120 shares traded.

Analyst Ratings Changes

Separately, Citigroup restated a "neutral" rating on shares of Eurofins Scient in a research note on Friday, July 25th. One analyst has rated the stock with a Strong Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold".

View Our Latest Analysis on Eurofins Scient

Eurofins Scient Trading Up 0.4%

The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. The company has a 50-day simple moving average of $75.20 and a two-hundred day simple moving average of $65.00.

About Eurofins Scient

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EUROFINS SCIENT Right Now?

Before you consider EUROFINS SCIENT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUROFINS SCIENT wasn't on the list.

While EUROFINS SCIENT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.